No reason to monitor plea against bar on repeat RTPCR on Covid patients: HC

The Delhi High Court said there was no reason to further monitor a plea challenging the bar on repeating RTPCR on Covid-19 positive patients

Delhi high court
Press Trust of India New Delhi
2 min read Last Updated : Nov 26 2021 | 8:14 PM IST

The Delhi High Court Friday said there was no reason to further monitor a plea challenging the bar on repeating RTPCR on COVID-19 positive patients in view of ICMR's stand that a doctor was free to recommend a re-test within 14 days of initial testing if therapeutically indicated.

A bench headed by Chief Justice D N Patel closed the proceedings on the petition by lawyer Karan Ahuja who challenged ICMR's May 4 advisory barring repeat of RTPCR on positive patients and said that the petitioner has the liberty to move court in future again in case of any grievance.

In view of the reply filed by the Director General of Health Services, Government of Delhi and ICMR, we see no reason to further monitor the case, said the bench also comprising Justice Jyoti Singh.

Ahuja had filed the petition earlier this year claiming that due to the ICMR advisory, neither he nor his family members could get tested again after spending more than 17 days in quarantine from April 28 when they had first tested positive.

ICMR responded that while it held that RTPCR test should not be done on COVID-19 positive patients, doctors could still recommend re-testing within 14 days of initial test.

That it is submitted that in respect of para (i) of the ICMR's Advisory dated 04.05.2021, a doctor may recommend a re-test of COVID 19, within 14 days of initial testing, if therapeutically indicated, the ICMR affidavit stated.

The Delhi government told the court that it was bound to give effect to advisories issued by ICMR, including the one under challenge which was issued in the wake of the second wave of the pandemic in order to optimize RTPCR testing infrastructure.

It also informed that as per WHO guidelines, a person may be released from isolation after 10 days from onset of symptoms, plus additional days without any symptoms.

The court had issued notice on the lawyer's petition on June 1.

The petitioner had contended that the May 4 advisory was "arbitrary, discriminatory and creates a paradoxical situation since a negative RTPCR report is compulsorily required by several other notifications issued by the respondents (Centre, ICMR and Delhi government)".

He had sought striking down of the clause in the advisory which barred repeating of an RTPCR test on someone who has already tested positive by way of Rapid Antigen Test (RAT) or RTPCR.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Nov 26 2021 | 8:14 PM IST

Next Story